Companies / Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc.

Nasdaq: AGIOCIK 1439222CAMBRIDGE, MAagios.com ↗

Financials · FY2025

Revenue$54.03M
Net income$-412.78M
Total debt—
Cash$99.65M
Diluted EPS$-7.12
Shares outstanding59.7M

Ownership

59.7M shares outstanding · as of Jul 24, 2026
0.67%Insiders
Ownership
Insiders0.67%401,117
10%+ / strategic10.29%6,144,145
Institutions94.72%56,551,470
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Goff BrianCEOChief Executive Officer · Director
0.28%164,548
Gheuens SarahChief Medical Officer
0.12%74,406
Jones CeciliaChief Financial Officer
0.08%49,328
Burns James WilliamChief Legal Officer
0.07%44,086
Milanova TsvetaChief Commercial Officer
0.07%41,591
Capello Jeffrey DDirector
0.02%10,865
Foster-Cheek Kaye IDirector
0.02%10,284
Viswanadhan KrishnanChief Corp Dev & Strategy
<0.01%5,141
Washburn Theodore James Jr.Principal Accounting Officer
<0.01%868

Institutional holders 243

View all →
HolderValue% of shares
BlackRock, Inc.$239.58M10.81%
Vanguard Group Inc$152.28M9.37%
Farallon Capital Management LLC$140.44M8.64%
State Street Corporation$131.14M5.92%
D. E. Shaw & Co., Inc.$90.70M4.49%
Armistice Capital, LLC$82.64M5.09%
Erste Asset Management GmbH$76.34M4.70%
Geode Capital Management, LLC$49.67M2.46%
Nomura Asset Management International Inc.$46.31M2.85%
Citadel Advisors LLC$36.72M2.26%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Dec 30, 2025Goff Brian
CEO
SellCommon stock$337.9K-12K
-8.37%
136,583
0.23% of shares
medium
Mar 2, 2026Goff Brian
CEO
SellCommon stock$239.4K-8K
-4.99%
157,466
0.26% of shares
medium
Mar 2, 2026Goff Brian
CEO
SellCommon stock$171.4K-6K
-3.47%
164,548
0.28% of shares
medium
Dec 30, 2025Goff Brian
CEO
SellCommon stock$168.8K-6K
-4.17%
143,103
0.24% of shares
medium
Mar 3, 2026Washburn Theodore James Jr.
Executive
SellCommon stock$152.3K-5K
-85.86%
868
<0.01% of shares
medium
Mar 2, 2026Goff Brian
CEO
SellCommon stock$112.1K-4K
-2.55%
147,733
0.25% of shares
medium
Mar 5, 2026Viswanadhan Krishnan
Executive
SellCommon stock$82.3K-3K
-36.53%
5,141
<0.01% of shares
low
Dec 30, 2025Jones Cecilia
Executive
SellCommon stock$79.4K-3K
-7.27%
37,394
0.06% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Farallon Capital Partners, L.P.Passive13G/A———
State Street CorporationPassive13G—3,108,145—
Armistice Capital, LLCPassive13G—3,036,000—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
AGIO——00847X104—